Vascular Graft Market is expected grow USD 5.95 billion at a CAGR 7.15% during the forecast 2022-2030
Vascular Graft Market Overview:
According to market research future, the Vascular Graft Market would increase USD 5.95 billion at a CAGR of 7.15% between 2022 and 2030. Vascular graft or vascular bypass is a surgical procedure that reroutes blood from one location of normal blood flow to another area of generally normal blood flow in order to bypass a damaged artery. Depending on the indication and the raw materials used to produce the graft, there are many vascular grafts available. Vascular grafts are utilized to provide hemodialysis access as well as to treat aneurysms, especially thoracic aneurysms, endovascularly.
The high incidence of abdominal aneurysms, the expanding geriatric population, and the rising prevalence of smoking and other aneurysm risk factors are the key drivers driving the growth of this market. These illnesses include atherosclerosis, pulmonary embolism, deep vein thrombosis, and other heart ailments, as well as a growth in the number of hospitals and surgery centers, which makes disease detection and treatment easier.
Major Market Key Players
Notable players of vascular graft market comprise Cardinal Health (US), Gore Medical (US), Terumo (Japan), C. R. Bard (US), Medtronic (Ireland), LeMaitre Vascular (US), B. Braun Melsugen AG (Germany), Endologix (US), Maquet (Germany), and Cook Medical (US).
The global vascular graft market has been segmented on the basis of raw material, indication, end-user, and region.
Based on raw material, the global vascular graft market has been segmented into polyester grafts, EPTFE grafts, polyurethane grafts, and biosynthetic grafts. While polyester grafts hold the major market share among all the segments, biosynthetic graft is considered to be the fastest growing segment.
Based on indication, the global vascular graft market has been segmented into endovascular aneurysm repair, peripheral vascular repair, and hemodialysis access. Endovascular aneurysm repair is considered to be the major segment among all the segments. The peripheral vascular repair segment is expected to be the fastest growing segment.
Based on end-user, the global vascular graft market has been segmented into hospitals and ambulatory surgical centers. Among these, the hospitals hold the major segment and are anticipated to maintain its dominance during the review period. The ambulatory surgical centers are the fastest growing segment across the globe.
The global vascular graft market span across four major regions, namely Americas, Europe, Asia-Pacific, and Middle East & Africa.
America dominates the global vascular graft market and is anticipated to maintain its dominance over the assessment period. The growth is attributed to the high prevalence of cardiovascular diseases, diabetes, and chronic kidney diseases. With the availability of state-of-the-art healthcare infrastructure and presence of reimbursement coverage, the market is set to flourish. Asia Pacific is presumed to register the fastest market growth owing to the growing prevalence of diabetes and cardiovascular diseases in this region. Also improving healthcare infrastructure and epidemiological transition which has resulted in high rate of premature death is anticipated to trigger the demand for minimally invasive grafting procedures.Recent Development
R. Bard creates medical devices to help healthcare professionals and patients with wellness and prevention, early diagnosis, treatment, and post-care management. The company's specialist goods and services are intended to treat peripheral vascular disease (PVD), end-stage renal illness, cardiac arrhythmias, urological disease, different malignancies, and soft tissue repairs by providing clients with vascular, urology, oncology, and surgical specialty items.
|Market Size||2030: USD 5.95 Billion|
|CAGR||7.15% CAGR (2022-2030)|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Raw material, Indication, End-user|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Cardinal Health (US), Gore Medical (US), Terumo (Japan), C. R. Bard (US), Medtronic (Ireland), LeMaitre Vascular (US), B. Braun Melsugen AG (Germany), Endologix (US), Maquet (Germany), and Cook Medical (US).|
|Key Market Opportunities||
|Key Market Drivers||
The vascular graft market is projected to grow at an 7.15% CAGR between 2022-2030.
Cardinal Health (US), Gore Medical (US), Terumo (Japan), C. R. Bard (US), Medtronic (Ireland), LeMaitre Vascular (US), B. Braun Melsugen AG (Germany), Endologix (US), Maquet (Germany), and Cook Medical (US).
The vascular graft market predicted to touch USD 5.95 billion by 2030
The Americas is projected to command the largest share in the vascular graft market.
Different strategies used by market players to create a dominance in the vascular graft market include collaborations, product development, strategic alliances, and others.
Hospitals will lead the vascular graft market.